Gabriel Griffin, MD

Dr. Griffin graduated from Duke University School of Medicine in 2013 and received his clinical residency and fellowship training in the Department of Pathology at the Brigham and Women’s Hospital followed by post-doctoral studies at the Broad Institute of MIT and Harvard. Dr. Griffin is now a principal investigator and member of the faculty in the Department of Pathology at the Dana-Farber Cancer Institute and Harvard Medical School, where he runs an independent research laboratory studying basic mechanisms of immune regulation in cancer.  Dr. Griffin also serves as a faculty member in the Division of Hematopathology at the Brigham and Women's Hospital, where he participates in the diagnosis of patients with hematologic malignancies.